Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Aminophylline vs Ondansetron for Prevention of Post-Dural Puncture Headache After Cesarean Section
IRCT2016110519470N50Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in post-dural puncture headache (PDPH) comparing Aminophylline arm with Ondansetron arm (2 arms). Primary endpoint: Incidence of post-dural puncture headache. Started Mar 2017; status: completed.
02
Drugs
aminophyllineondansetron
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT2016110519470N50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016110519470N50.